MENU
+Compare
APDN
Stock ticker: NASDAQ
AS OF
Sep 5, 04:59 PM (EDT)
Price
$2.31
Change
-$0.57 (-19.79%)
Capitalization
1.49M

APDN Applied DNA Sciences Inc Forecast, Technical & Fundamental Analysis

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA)... Show more

APDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for APDN with price predictions
Sep 04, 2025

APDN in upward trend: price may jump up because it broke its lower Bollinger Band on August 19, 2025

APDN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 49 cases where APDN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where APDN advanced for three days, in of 157 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for APDN turned negative on August 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APDN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for APDN entered a downward trend on September 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.206) is normal, around the industry mean (10.335). P/E Ratio (0.001) is within average values for comparable stocks, (138.417). APDN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.673). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. P/S Ratio (0.399) is also within normal values, averaging (9.363).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. APDN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APDN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
APDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of botanical deoxyribonucleic acid based security and authentication solutions

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Information Technology Services
Address
50 Health Sciences Drive
Phone
+1 631 240-8800
Employees
55
Web
https://www.adnas.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PR14.330.49
+3.54%
Permian Resources Corp
HOVNP19.900.10
+0.51%
Hovnanian Enterprises
DYN13.24-0.24
-1.78%
Dyne Therapeutics
NCMI4.30-0.17
-3.80%
National CineMedia
APLT0.47-0.05
-9.07%
Applied Therapeutics

APDN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, APDN has been closely correlated with BNR. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if APDN jumps, then BNR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APDN
1D Price
Change %
APDN100%
-1.71%
BNR - APDN
85%
Closely correlated
+6.29%
SINT - APDN
84%
Closely correlated
-17.36%
SSKN - APDN
80%
Closely correlated
-9.57%
GCTK - APDN
72%
Closely correlated
-3.37%
AIMD - APDN
38%
Loosely correlated
-2.94%
More

Groups containing APDN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APDN
1D Price
Change %
APDN100%
-1.71%
APDN
(5 stocks)
36%
Loosely correlated
+2.21%